Riskpilot← Back to searchSign inGet full accessAUTOPHARMA ApS
APSActiveCVR 35402268Hvidovre Strandvej 59BEngineering activities and related technical consultancy · NACE 7112Est. 20131 employeeswww.autopharma.dk
Revenue 2024
DKK 1,4M
EBITDA margin
44.8%
+4% vs 2023
Equity ratio
79.3%
Financial strength
Net profit 2024
DKK 631K
+23% vs 2023
| Revenue | DKK 1,4M | — |
| EBITDA | DKK 645K | +4% |
| Net profit | DKK 631K | +23% |
| Total assets | DKK 1,5M | -9% |
| Equity | DKK 1,2M | +98% |
| Employees | 1 | — |
Legal name
AUTOPHARMA ApS
CVR number
35402268
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
1. juli 2013
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion i forening
Company purpose
Selskabets formål er at levere konsulentydelser pt. indenfor pharma og food industrien, specielt i form af softwareprogrammering, validering af styringssystemer, test samt onside support og dermed tilknyttede aktiviteter. Selskabet kan efter direktionens beslutning drive anden virksomhed, der står i naturlig forbindelse med det nævnte hovedformål.
Address
Hvidovre Strandvej 59B
Phone
+4531388565
Email
yl@autopharma.dk
Website
www.autopharma.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 672 | 814 | 779 | 790 | 871 | 1.205 | — | — | — | — | 1.441 |
| Staff expenses | -672 | -597 | -666 | -646 | -625 | -731 | -730 | -781 | -681 | -630 | -795 |
| EBITDA | -73 | 138 | 113 | 145 | 246 | 474 | 312 | 302 | 621 | 623 | 645 |
| Depreciation & amort. | -0 | -0 | -0 | -13 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -73 | 138 | 113 | 132 | 246 | 474 | 312 | 302 | 621 | 623 | 645 |
| Net financials | -15 | 0 | 0 | 0 | 0 | 0 | -2 | -3 | -8 | 33 | 164 |
| Profit before tax | -88 | 138 | 113 | 132 | 2.446 | 474 | 310 | 299 | 613 | 656 | 809 |
| Tax | -0 | 11 | 25 | 29 | 54 | 104 | 68 | 66 | 135 | 144 | 178 |
| Net profit | -88 | 127 | 88 | 103 | 192 | 370 | 242 | 233 | 478 | 512 | 631 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 253 | 289 | 350 | 366 | 531 | 862 | 1.110 | 1.058 | 1.124 | 1.610 | 1.467 |
| Equity | -8 | 119 | 168 | 80 | 143 | 263 | 345 | 644 | 492 | 589 | 1.163 |
| Long-term debt | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 261 | 159 | 181 | 286 | 388 | 599 | 765 | 414 | 632 | 1.022 | 304 |
| Total debt | 261 | 170 | 181 | 286 | 388 | 599 | 765 | 414 | 632 | 1.022 | 304 |
EBITDA margin
44.8%
This company
15.8%
Market median
+184% vs market
20142024
Equity ratio
79.3%
This company
38.2%
Market median
+108% vs market
20142024
Return on equity
54.3%
This company
18.4%
Market median
+195% vs market
20142024
Net profit margin
43.8%
This company
8.1%
Market median
+441% vs market
20142024
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
20142024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20142024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CF Founder | Founder | 2013 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2021 | |
AP23 ApS | Company | 33.3% | 33.3% | 2025 |
Landinspektørholdingselskabet HS59 ApS | Company | 20.0% | 20.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AUTOPHARMA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carsten Flyger Jørgensen | Founder | 0 companies |